Case Report | Open Access
Volume 2024 - 3 | Article ID 244 | http://dx.doi.org/10.51521/WJCRCI.2024.31-226
Academic Editor: John Bose
Enver Sukru Goncuoglu1, Attila Onmez2
1Depatment of Internal
Medicine, NB Kadikoy Hospital, Turkish Diabetes Association, Istanbul-Turkiye
2Department of Internal Medicine, Duzce University,
Duzce-Turkiye
Corresponding Author: Enver Sukru Goncuoglu, Depatment of Internal Medicine, NB Kadikoy Hospital,
Turkish Diabetes Association, Istanbul-Turkiye
Citation: Enver Sukru Goncuoglu, Attila Onmez (2024). Effects
of Close Monitoring with Telemedicine on Glycemic Control in an Immunocompromised
Patient with Type 1 Diabetes. World J Case Rep Clin Imag. 2024 Mar-Apr;3(1)1-5.
Copyrights © 2024, Enver
Sukru Goncuoglu, et al. This article is licensed under the Creative CommonsAttribution-Non-Commercial-4.0-International-License-(CCBY-NC)
(https://worldjournalofcasereports.org/blogpage/copyright-policy). Usage and
distribution for commercial purposes require written permission.
ABSTRACT
Background: Hypoglycaemia
is a condition that can have a severely negative impact on the life of a person
with diabetes, making blood sugar control difficult. Closed loop hybrid insulin
pump therapy has been shown to be highly effective in managing this condition,
resulting in rapid improvement in glycaemic control and a reduction in the
frequency and severity of hypoglycaemic attacks. This article presents a case
study in which a type 1 diabetic achieved significant improvement in glycaemic
control after switching to a closed-loop hybrid insulin pump system and
receiving remote monitoring. Case
presentation: A 57-year-old female with type 1 diabetic who had all micro
and macro vascular complications. Her blood glucose control was achieved
rapidly after switching to insulin pump and her daily life was became more
active and normalised. Conclusion: This study highlights rapid
achievement of glycemic control, minimization of hypoglycemic episodes, and
remote monitoring of the person with type 1 diabetes using a closed circuit
insulin pump system. The study's evaluation is objective and based on clear
evidence.
Keyowrds:
Type 1 Diabetes, Glycemic Control, Immunocompromised
Patient, hyperglycemic or hypoglycemic emergencies, Hypertension
.png)
.jpg)
.gif)
.jpg)
